Document Detail


Speed of onset.
MedLine Citation:
PMID:  7675987     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Speed of onset can be an important attribute of drug product performance. In studies employing appropriate designs and outcome measures, it is theoretically possible to make internally valid comparisons of the distribution of onset times associated with the use of two or more drug products. The external validity of such estimates is still potentially arguable. Steps that may be taken to enhance the likelihood that the results of such comparative studies will be accepted as valid bases for comparative claims are discussed.
Authors:
P Leber
Related Documents :
12380577 - National survey on the attitudes of canadian physicians towards drug-detailing by pharm...
16867787 - Recent applications of electrochemical techniques to the analysis of pharmaceuticals.
24982327 - Cardiotoxicity of molecular-targeted drug therapy.
24001227 - Recent advances in the development of antiviral agents using computer-aided structure b...
17048477 - The blood-brain barrier and brain drug delivery.
11768327 - New developments: chloroquine-resistance in plasmodium falciparum.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Psychopharmacology bulletin     Volume:  31     ISSN:  0048-5764     ISO Abbreviation:  Psychopharmacol Bull     Publication Date:  1995  
Date Detail:
Created Date:  1995-10-17     Completed Date:  1995-10-17     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0101123     Medline TA:  Psychopharmacol Bull     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  37-40     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Mental Disorders / drug therapy*,  psychology
Psychiatric Status Rating Scales
Psychotropic Drugs / therapeutic use*
Time Factors
Chemical
Reg. No./Substance:
0/Psychotropic Drugs

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterizing onset in psychopharmacological clinical trials.
Next Document:  Are 2-week trials sufficient to indicate efficacy?